Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Citeline Connect-Savvy Cooperative Partnership Provides Patient Insights to Optimize Clinical Trial Websites


Citeline Connect, an end-to-end clinical trial engagement and recruitment solution, seeking to incorporate the patient voice during the design stage of custom clinical trial websites, partners with Savvy Cooperative, a research platform that connects diverse patients and caregivers with accessible and interactive ways to share their experiences with health innovators, for patient feedback on the end-user experience.

During the two-day project, 15 patients analyzed visuals and provided their feedback on different elements of a Citeline Connect clinical trial landing page, screening questions, and post-screen interactions. Specific feedback focused on trial details such as side effects, recruitment of diverse applicants, eligibility criteria, and patient-centric aspects such as plain language and

user-friendliness.

“When someone starts researching clinical trial options, they are met with a tidal wave of information,” said Christina Masturzo, Citeline Connect Head of Product, Patient Engagement & Recruitment. “We partnered with Savvy because they could connect us directly with patients and ensure the voice of patients is reflected in our work. We want to build educational content that will help patients with their decision to participate. The best way we can do that is to learn from them directly through the research that Savvy offers.”

“Patients are dealing with enough on top of weighing the decision to commit to a clinical trial. The kindest — and frankly most effective — thing we can do is make that experience as easy, reassuring, and informative as possible,” said Jen Horonjeff, CEO & Founder of Savvy Cooperative. “Together, we asked a diverse group of patients who have clinical trial experience to use their expertise to create a more informed and supportive clinical trial experience. We are thrilled that the Citeline Connect team values patient experience, and chose to unlock actionable insight throughout their development process.”

Citeline Connect has integrated learnings from the project into a set of best practices used in creating clinical trial websites for sponsors. Websites designed following these guidelines and based on the new user experience have seen an average 6% decline in visitor drop-off rate.

For additional details, read the full case study on the project.

About Citeline Connect

Citeline Connect is the most comprehensive solution for clinical trial engagement and recruitment. This solution revolutionizes how patients find and enroll in clinical research across the globe by combining the power of data-driven technology with the reach of proprietary HCP networks and 85+ pre-vetted partners from an industry-first patient referral collective. For more information, visit CitelineConnect.com.

About Savvy Cooperative

Savvy Cooperative is the first and only patient-owned public benefit co-op that helps the healthcare industry get the patient insights they need to create better patient-centered products and services. Savvy’s research platform allows companies and innovators to connect directly with diverse patients and caregivers across rare and common conditions in order to participate in market research, user-testing, consumer insights and co-design opportunities. Savvy was named one of Entrepreneur magazine’s 50 Most Daring Entrepreneurs for its unique model that empowers patients to use their health experiences and leverage their networks to increase diversity and inclusion in product development and commercialization. For more information about Savvy Cooperative, please visit savvy.coop.

Share article on social media or email:

NCCAOM and ASA Partner to Celebrate Acupuncture and Herbal Medicine Day 2022


“In honor of AHM Day, patients should ensure that the practitioner they visit is properly trained and is NCCAOM Board-Certified,” said Mina Larson, M.S., MBA, CEO of NCCAOM.

The National Certification Commission for Acupuncture and Oriental Medicine (NCCAOM)®, http://www.nccaom.org, and American Society of Acupuncturists (ASA), http://www.asacu.org, are collaborating to promote nationwide observations of the 20th Annual Acupuncture and Herbal Medicine (AHM) Day on Oct. 24. In honor of AHM Day. Both organizations have joined forces to encourage research and educate the public about the many benefits of acupuncture and herbal medicine for treating the millions of Americans suffering from pain, addiction, and many other ailments. This year we are celebrating our past in recognition of our 40th Anniversary and embracing our future with a wide array of celebrations at http://www.ahmday.org.

To help advance the medicine and increase access to qualified acupuncturists, the NCCAOM and the ASA are working together with U.S. Representative Judy Chu (D-CA) to establish acupuncturists as a Medicare provider group. H.R. 4803, The Acupuncture for our Seniors Act, would authorize the Medicare program to recognize acupuncturists to provide covered acupuncture services to Medicare beneficiaries (those age 65+) without supervision. The passage of H.R. 4803 would increase access to acupuncturists and provide more pain-management options for Medicare beneficiaries. Look for more information about the Medicare-recognition effort the NCCAOM and ASA websites at, https://www.nccaom.org/advocacy-regulatory/, http://www.asacu.org.

“More and more patients are realizing that acupuncture is an effective, non-pharmacologic and low-risk method of treating or controlling chronic conditions. Increasing insurance coverage for acupuncture services helps those seeking a whole person approach to their symptoms. By celebrating Acupuncture and Herbal Medicine Day and the 40th anniversary of the establishment of this medicine, we hope to bring further awareness to those in need and through our efforts with Medicare, we hope to improve access.” said Olivia Hsu Friedman, DACM, L.Ac., Chair of ASA.

“Consumer use of acupuncture and herbal medicine has increased significantly since NCCAOM was established 40 years ago,” said Mina Larson, M.S., MBA, CEO of NCCAOM. “We are so delighted to celebrate this milestone year while continuing to provide greater access through our collaborative Medicare initiative. In honor of AHM Day, patients should ensure that the practitioner they visit is properly trained and is NCCAOM Board-Certified.”

This year marks the 40th anniversary of the AHM leadership organizations in the United States. To celebrate this milestone the NCCAOM has partnered with the American Society of Acupuncturists (ASA), Accreditation Commission for Acupuncture and Herbal Medicine (ACAHM), and Council of Colleges of Acupuncture and Herbal Medicine (CCAHM) to celebrate the 40th anniversary of the AHM profession. These four pillar organizations in the AHM profession are combining forces to honor our profession’s founding practitioners this Acupuncture and Herbal Medicine Day 2022. To celebrate the 40th Anniversary, a Reflection Photo Drive has been conducted by ASA and NCCAOM. The drive encourages participants to upload a photo of a leader in the profession, along with a tagline for their achievements and a 250 – 500 words essay about that founding father/mother who has championed one or more of the below categories. The purpose of this celebratory event is to honor those who have led the way in our profession.

The NCCAOM and ASA will co-host a virtual Town Hall meeting to celebrate our 20th Acupuncture and Herbal Medicine Day. While the actual AHM Day is October 24th, the live webinar will be on Sunday, October 23, 2022 at 4PM Pacific/6PM Central/7 PM Eastern. Jewel Thais-Williams, MSOM, LAc., Arthur Fan, CMD, PhD, LAc., and Effie Chow, PhD, RN, LAc. will share these fascinating stories. Their inspiring stories highlight the contributions of practitioners in the United States whose work significantly impacts advocacy, community outreach, and the laying of the foundation of our profession. The Twon Hall will be hosted by Afua Bromley, MSOM, LAc, Dipl Ac (NCCAOM) & LiMing Tseng, MAcOM, LAc, Dipl OM (NCCAOM), co-chairs of the NCCAOM & ASA Cultural Competency Task Force.

About ASA

The Mission of the American Society of Acupuncturists, http://www.asacu.org is advancing the professional practice of acupuncture as a whole system of medicine through advocacy, education, and research. Their vision is to see that acupuncturists are valued leaders and partners in the American healthcare system, and patients have equitable access to our care.

About NCCAOM

The National Certification Commission for Acupuncture and Oriental Medicine (NCCAOM)®, http://www.nccaom.org, is a non-profit 501(c)(6) organization established in 1982. NCCAOM certification or a passing score on the NCCAOM certification examinations are documentation of competency for licensure as an acupuncturist by 46 states plus the District of Columbia which represents 98 percent of the states that regulate acupuncture. All NCCAOM certification programs are currently accredited by the National Commission for Certification Agencies (NCCA). To find an NCCAOM National Board-certified Acupuncturist in your area, click on Find a Practitioner at http://www.nccaom.org.

For more information on AHM Day, please visit http://www.ahmday.org.

Share article on social media or email:

OpsHub and InCycle Help a Leading Medical Device Company to Accelerate Innovation with Tool Modernization


“Successful customers are embracing new tools, and platforms and adopting world-class software development practices to dramatically reduce time to production and accelerate innovation in response time to dynamic market conditions,” said Martin Rajotte, President at InCycle Software.

OpsHub Inc. and InCycle Software enable a global imaging products company to accelerate innovation by modernizing their legacy ALM infrastructure and migrating to Azure DevOps. InCycle, a leading consulting company that helps businesses achieve their digital transformation goals with successful adoption of the cloud and application modernization solutions, partnered with OpsHub the market leader in Digital Mesh solutions.

Businesses today work with a vast amount of data often locked in siloed, legacy systems. Teams that want to accelerate the pace of their delivery look at modern, agile tools such as Azure DevOps to fulfil the mandate of quality with speed. But legacy data locked in obsolete or unwieldy tools frequently becomes a key deterrent that prevents teams from migrating to a modern, user-friendly and fit-for-purpose tool. The teams at OpsHub and InCycle designed a migration strategy leveraging OpsHub Migration Manager to address the complexities of tool modernization and completed the migration successfully without systems downtime or productivity loss.    

Speaking about the successful migration journey, Martin Rajotte, President at InCycle Software said,

“Modern software development and rapid innovation are key competitive advantages. Successful customers are embracing new tools, and platforms and adopting world-class software development practices to dramatically reduce time to production and accelerate innovation in response time to dynamic market conditions. In the digital economy, whoever builds the fastest software wins.”

“Agile innovation teams need access to the right information in the right tool at the right time to make data-driven decisions and improve their lead times. For many enterprises, legacy tools are impeding key transformation initiatives and processes that can lead to innovation, said Sandeep Jain, CEO of OpsHub Inc. “Our partnership with InCycle Software empowered the customer to benefit from a seamless data migration and avoid getting locked in obsolete tools and information silos.”

OpsHub and InCycle are also delighted to announce a webinar on ‘Accelerate Innovation by Fully Leveraging Integration and Azure DevOps” on Tuesday, November 8th, 2022.

About OpsHub

OpsHub is the leading provider of Digital Mesh solutions for agile innovative teams. OpsHub increases the pace of innovation of agile teams at hundreds of enterprise customers. OpsHub democratizes effective decision-making by offering complete information to each team member in the tool of their choice. As a result, enterprises using OpsHub can deliver innovative products and services faster with higher quality, and at a lower cost.

About InCycle Software

InCycle provides challenging thought leadership and hands-on professional services to help businesses successfully leverage, adopt and migrate to Microsoft Azure. By combining the cloud platform, modern application designs, intelligent data, security and advanced DevOps practices, InCycle helps customers modernize applications and achieve new levels of success.

Share article on social media or email:

Acara Partners in Branford, CT Wins Award for ‘Best Practice Management Company’ in The Aesthetic Guides’ Annual Aesthetic Awards


Acara Partners in Branford, CT wins award for ‘Best Practice Management Company’ in The Aesthetic Guide’s Annual Aesthetic Awards, presented in their Sept.-Oct. 2022 issue.

Acara Partners in Branford, CT wins award for ‘Best Practice Management Company’ in The Aesthetic Guide’s Annual Aesthetic Awards, presented in their Sept.-Oct. 2022 issue.

Acara Partners in Branford, CT has been recognized as the ‘The Best Practice Management Company’ of 2022…

Acara Partners in Branford, CT has been recognized as the ‘The Best Practice Management Company’ of 2022 in The Aesthetic Guide’s annual Aesthetic Awards, presented in The Aesthetic Guide’s Sept.-Oct. 2022 issue. The Aesthetic Guide is a medical aesthetic publication that recognizes, once a year, the best of the best in the industry, voted by peers.

Acara Partners is a business consulting agency that specializes in business development, marketing strategy, corporate consultation, strategic planning, sales and operations for the medical aesthetic industry. Acara Partners owner Francis X. Acunzo has also been recognized by The Aesthetic Guide this year, winning the ‘Lifetime Achievement Award’ for his exemplary work and commitment to the aesthetic medical industry. Acunzo and the other nominees of The Lifetime Achievement Award have demonstrated excellence and passion for their craft, in addition to high ethical standards and innovation in the industry. Francis is the second-ever non-physician to win the ‘Lifetime Achievement Award.’

Acara’s team of consultants and marketing professionals has worked with hundreds of aesthetic medical practices and has developed more than 170 medical spas nationwide. Acara Partners is one of the aesthetic medical industry’s preferred consulting groups for physicians and entrepreneurs that are developing their own aesthetic medical practice. Acara’s 99% success rate and client satisfaction make them the go-to consultant group to bring medspas to life—from conceptualization to open doors.

During the next six months, Acara will be partnering to open six to eight new medspas from coast to coast. The consulting team at Acara Partners typically takes on one to two new clients per month.

For more information about Acara Partners, please call 203.488.0028. Acara Partners is located at 944 Main St., Branford, CT 06405.

About Acara Partners

Acara Partners is a business consulting agency that was founded in 2004 by Francis X. Acunzo and his wife Colleen Acunzo, who are considered the founders of the medspa industry, opening the first resort spa in the northeast in 1985. Acara Partners specializes in business development, marketing strategy, corporate consultation, strategic planning, sales and operations.

About The Aesthetic Awards in The Aesthetic Guide

The Aesthetic Awards celebrate the very best of aesthetic medicine, highlighting the achievements of practitioners, professionals and product manufacturers in areas such as surgical and nonsurgical treatments, practice management and industry innovation.

Share article on social media or email:

CODAC Behavioral Healthcare to Present at 2022 AATOD Conference


We are especially excited to be presenting at this annual meeting at such an important time when amazing work is being done to battle opioid use disorder, but, at the same time, risks are increasing…

CODAC Behavioral Healthcare, the largest non-profit, outpatient provider for opioid treatment in Rhode Island, today announced that it will be presenting at two sessions during the 2022 American Association for the Treatment of Opioid Dependence, Inc. (AATOD) Conference to be held October 30 – November 3, 2022 in Baltimore, Maryland at the Baltimore Hilton Inner Harbor. The theme of this national and international Conference is “The Power of Collaboration. CODAC experts plan to highlight five-year outcomes for its innovative program of medication for opioid use disorder (MOUD) behind bars and provide a blueprint for treating the aging and elderly in opioid treatment programs (OTPs).

“We are especially excited to be presenting at this annual meeting at such an important time when amazing work is being done to battle opioid use disorder, but, at the same time, risks are increasing – primarily product adulterants (fentanyl and others) and barriers to accessing quality care — that have resulted in increasing overdose and death,” said Linda Hurley, President/CEO of CODAC. “We look forward to sharing our models, best practices and outcomes alongside some of the most cutting-edge topics and presenters in our field, nationally and internationally.”

CODAC’s presentations at AATOD 2022 will be as follows:

· Tuesday, November 1, 2022 — 1:30 PM – 3:00 PM

Workshop: Patient Care & Best Practices

1 – Effectively Treating the Aging and Elderly in Opioid Treatment Programs: A Comprehensive Model

Primary Presenter(s): Linda Hurley, MA CAGS, President and Chief Executive Officer, CODAC

Co-Presenter(s): Andrew C. Stone, MD, Medical Director of CODAC Providence; Catherine DeGood, DO, Chief Medical Director for CODAC

From program/schedule: Opioid treatment programs have seen a dramatic increase in our aging populations, those who have been in recovery for decades with us and those who have developed a late onset opioid use disorder. The aging process creates a new challenge to comprehensive, integrated services for those who come to us for care. This presentation will provide a blueprint for a cost effective, health home program for aging patients addressing the medical, metabolic, cognitive, social, pharmacologic and fiscal changes that must be addressed to successfully support recovery for our older patients.

· Tuesday, November 1, 2022 — 4:00 PM – 5:30 PM

Workshop B: Community Partners & Continuum of Care

B5 – MAT (medication-assisted treatment) in Corrections: 5 Years of Increasing Success. A How-To and Why Story

Primary Presenter(s): Linda Hurley, MA CAGS, President and Chief Executive Officer, CODAC

Co-Presenter(s): Rosemarie Martin, PhD, Associate Professor, Brown University School of Public Health, Providence, Rhode Island; Justin Berk, MD MPH MBA, Medical Director, Rhode Island Department of Corrections, Providence, Rhode Island

From program/schedule: Research indicates that the risk of overdose is increased following release from prison and jail. In 2014 and 2015, 21% of all fatal overdose victims in RI were incarcerated in the two years prior to death, an increase from 9% in 2009. Medication for opioid use disorder (MOUD) is the most effective evidenced-based approach to treat opioid use disorder. Although MAT has been proven effective, few correctional facilities in the US offer treatment with methadone, buprenorphine, or naltrexone. This workshop provides positive outcomes of 5 years ~ the question is not “why or how” it is now “how soon” to treat.

About CODAC Behavioral Healthcare

CODAC Behavioral Healthcare, a non-profit organization founded in 1971, is Rhode Island’s oldest and largest provider of outpatient services for opioid use disorder, other substance use disorders, and concurrent behavioral health challenges. With eight locations across Rhode Island, CODAC has attained Center of Excellence designations for each of its treatment sites. CODAC has done extensive work with individuals involved in the criminal justice system since 1994 and, in 2016, launched a program with the Rhode Island Department of Corrections (RIDOC) that was the first of its kind in the United States to screen all inmates for opioid use disorder and provide medication-assisted treatment (MAT) for those in need. Results from CODAC’s RIDOC program have been studied and published, and the program has been recognized as “a model for all 50 states” by the Department of Justice, SAMHSA and multiple other national agencies. In addition, CODAC is now licensed in Massachusetts to operate an Opioid Treatment Program (OTP). For more information about CODAC, visit: http://www.codacinc.org

About AATOD 2022

The 2022 American Association for the Treatment of Opioid Dependence, Inc. (AATOD) Conference will be held in Baltimore, Maryland at the Baltimore Hilton Inner Harbor, October 30 – November 3, 2022. The 2022 conference theme is “The Power of Collaboration.” The intent is to educate and promote acceptance and integration of MAT options by patients, families, clinicians, the medical system, judicial systems, government, policymakers, social service administrations, and the general public. For more information, visit https://www.eventscribe.net/2022/AATOD/

Media Contact:

Bill Gordon; PR/Media Relations

646-924-6146

billgordon37@hotmail.com

Alisha Bourdeau,CFO; CODAC

(401) 654-8738

abourdeau@codacinc.org

Share article on social media or email:

Andrew Keck Joins Abt Associates as Regional VP for West Africa, Middle East, and North Africa


Andrew Keck, a global development executive with more than 30 years of experience, has joined Abt Associates as regional vice president for West Africa, Middle East, and North Africa.

Andrew Keck, a global development executive with more than 30 years of experience, has joined Abt Associates as regional vice president for West Africa, Middle East, and North Africa (WAMENA). He provides strategic leadership for Abt’s regional work with clients such as the U.S. Agency for International Development (USAID) and the Foreign, Commonwealth & Development Office. Keck focuses on portfolio strategy and project performance, and he sets the operating plan for the WAMENA region.

Before joining Abt, Keck served as Tetra Tech’s director, water and sanitation sector, overseeing business growth, project quality, and thought leadership in the sector. He oversaw a diverse team working in more than 20 countries that managed a $270 million portfolio. He previously held a series of technical and leadership roles over 16 years at International Resources Group (IRG), including as global director overseeing programs in agriculture, climate, environment and water, and as Chief of Party for projects in Senegal and Madagascar. In addition, Keck worked for the World Bank for 11 years, including as coordinator to the multi-donor secretariat for Madagascar’s second environment program.

He holds an M.A. in Environmental Management from Duke University and a B.A. in Economics and French from Allegheny College.

###

About Abt Associates

Abt Associates is a global consulting and research firm that combines data and bold thinking to improve the quality of people’s lives. We partner with clients and communities to advance equity and innovation—from creating scalable digital solutions and combatting infectious disease, to mitigating climate change and evaluating programs for measurable social impact—and more.

http://www.abtassociates.com

Contact: Stan Crock

stan_crock@abtassoc.com

(301) 347-5402

Share article on social media or email:

Done., Patient Advocates, and Stakeholders Call For Vital Patient Access To Telehealth


News Image

…As Americans and providers continue to see the benefits of telehealth, we are pleased to participate in this discussion about the vital role that platforms like Done have played in bridging gaps in access to high-quality care for patients across the United States…

The founder of Done. Global Inc., a leading telehealth provider of services for people with attention-deficit/hyperactivity disorder (ADHD), joined renowned medical experts, patients, and a former member of Congress during a policy briefing to advocate for regulatory relief that would permanently allow some clinicians to prescribe medications online without the need to meet in person.

The “special registration” designation, a provision for providers seeking to prescribe controlled substances via telehealth, falls under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 and has yet to be effectuated by the Drug Enforcement Administration (DEA) through the promulgation of implementing regulations. Generally, to prescribe controlled substances via telehealth a provider has to first have had an in-person encounter with the patient. However, the in-person requirement has been suspended during the declared federal Public Health Emergency but could be changed at any time. After 14 years of inaction, DEA submitted a draft regulation to the White House Office of Management and Budget on March 17, 2022, and no action has yet to be taken.

The briefing panelists included former Rep. Bart Stupak (D-Mich.), who represented Michigan’s 1st District from 1993-2011 and is now a Partner at Venable LLP; two congressional staffers; Dr. Zoe Martinez, Clinical Director for Done Health P.C. and board-certified psychiatrist from UCLA who previously worked at institutions like Kaiser Permanente; and the Founder of Done. Global Inc., Ruthia He.

“With more than 17 million people with ADHD in the U.S. and less than 30,000 psychiatrists to treat them, we hope to bridge the gap by providing a patient-first, technology-powered ADHD management platform that connects patients with psychiatric board-certified clinicians for services, including clinical consultations, chronic care management, and 24/7 care team support,” said He during her opening remarks. “As Americans and providers continue to see the benefits of telehealth, we are pleased to participate in this discussion about the vital role that platforms like Done have played in bridging gaps in access to high-quality care for patients across the United States. However, it would be disheartening to see that these patients we have helped would not be able to continue their care after the PHE [public health emergency] expires.”

The ability to prescribe medications without seeing someone in person is particularly critical for people living in remote parts of the country where medical access is difficult or even non-existent and for anyone who lives with physical disabilities or additional diseases, disorders, or behaviors that make it virtually impossible to leave their home and travel to a medical facility. He and others also referenced the fact that adults with ADHD are five times more likely to die by suicide in the absence of proper treatment.

“Telehealth has been groundbreaking for many patients who do not have easy access to doctors, never mind specialty providers,” said Dr. Martinez. “COVID may have provided a reason to loosen some restrictions, but the need for increased access was there long before that particular health crisis.”

Participants in the briefing also referenced a letter from May 2022 addressed to Anne Milgram, DEA Administrator, and signed by the bipartisan leaders of the Health, Communications & Technology, and Consumer Protection & Commerce Subcommittees of the House Energy and Commerce Committee. The letter implores the DEA to develop the requisite framework for designation of “special registration” and deems its inaction “unacceptable.”

Done. executives will also submit a letter to President Joe Biden to request immediate attention on this issue and present findings and testimonials from patients – in-person – that underscored the pressing need for the DEA to take action.

Silvia S., who works in healthcare, in her remarks at the briefing shared her experience with how difficult it is to find ADHD treatment. And Dave W., a working professional and briefing panelist, said that he struggled to find adult ADHD care in his state. When he learned that his daughter also has ADHD he described much of the medical advice they received as subpar before discovering Done.

Throughout its existence, Done. has adhered to stringent standards to ensure the safety of patients. Before seeing a clinician, all patients must complete screenings for current controlled substance use and clinically significant depression and/or anxiety. It is crucial for the potential patient to go on to the initial assessment by a board-certified or eligible psychiatrist or psychiatric mental health board-certified nurse practitioner.

If that clinician decides the potential patient can benefit from treatment, the clinician will prepare a treatment plan and may issue prescriptions (enough for 30 days) in accordance with state/federal regulations. Throughout their treatment, patients complete symptom reports and health tracking and go through regular monthly check-ins on the platform.

October is ADHD Awareness Month – the same month in which World Mental Health Day takes place. The message at this time from Done. and others is clear: the White House should release the draft regulation so the DEA can move forward with finalizing a “special registration” process so Americans can continue to receive fundamental access to mental-health treatment.

About Done.

Done. is a digital health platform dedicated to empowering everyone living with attention deficit and hyperactivity disorder (ADHD) to reach their fullest potential. Through a patient-first, technology-powered ADHD treatment platform, industry-leading digital health company, Done. is making high quality psychiatric chronic care management more accessible and affordable for patients. To learn more about the platform, visit: http://www.donefirst.com.

Media Contact: press@donefirst.com

Share article on social media or email:

Catalent Expands Biologics Analytical Capabilities with New Laboratories at Center of Excellence in Kansas City, Missouri


Catalent's facility in Kansas City, Missouri

Catalent’s facility in Kansas City, Missouri

Our team at Kansas City serves as a strategic partner for customers of all sizes, and this expansion will allow it to support the increased demand and assay requirements for broad-based and orthogonal analytical CMC services.

Catalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced a $12 million expansion program to increase biologics CGMP analytical capabilities at its flagship facility in Kansas City, Missouri. The project will see the addition of two new analytical development laboratories to support the growing demands of assay development for both traditional biologic and advanced biologic modality programs.

The first of the two new laboratories will cover approximately 3,500 square feet and will be completed by the end of October 2022, with the second, measuring 3,000 square feet, due to be operational in the first quarter of 2023. The expansion will create approximately 50 new scientific jobs at the site by February 2023.

The additional capacity will increase the capabilities that Catalent has across its network in both standalone services and integrated development programs. In recent months, Catalent has expanded its CMC large molecule analytical services at Kansas City to include additional services in excipient and media components support, extractable and leachable testing, droplet digital PCR technologies (ddPCR), and next-generation sequencing (NGS), to support customers’ growing needs to accelerate programs and meet regulatory requirements.

“The need for timely analytical support in development, characterization and CGMP testing is critical for innovators across the biologics pipeline, with delays affecting the overall time to get new drugs into the clinic, and ultimately to patients,” said Jeremie Trochu, Division Head for BioAnalytics at Catalent. “Our team at Kansas City serves as a strategic partner for customers of all sizes, and this expansion will allow it to support the increased demand and assay requirements for broad-based and orthogonal analytical CMC services for both traditional biotherapeutics and advanced modalities such as antibody-drug conjugates, cell and gene therapies and mRNA vaccines.”

Catalent’s Kansas City facility is a center of excellence for its standalone biologics analytical services business, with over 30 years of experience providing cell-based assays and characterization studies for drug substance, drug products and intermediates, for both innovator and biosimilar products. It also provides a range of integrated services for oral solid dosage forms as well as comprehensive clinical packaging and supply services. In April 2022, Catalent announced the completion of an expansion project to increase capacity and capabilities for producing encapsulated oral solid dose forms at the site.

About Catalent Biologics

For nearly three decades, Catalent Biologics has built capabilities and expertise in development, manufacturing, and analytical services, now spanning new biological entities, biosimilars, plasmid DNA, cell and gene therapies, vaccines, sterile injectables, mRNA, and antibody-drug conjugates. It has developed 600+ antibodies and 80+ recombinant proteins, with 120+ active clinical trials and 16 marketed biotherapeutics use GPEx® cell line engineering technology. An additional 45+ commercially approved products have employed Catalent Biologics’ manufacturing and packaging capabilities.

Catalent Cell & Gene Therapy is an industry-leading technology, development, and manufacturing partner for advanced therapeutics. With a comprehensive cell therapy portfolio and deep expertise in viral vector development, scale-up and manufacturing, Catalent is a full-service partner for plasmid DNA, adeno-associated viral (AAV) and other viral vectors, viral vaccines, iPSCs and autologous and allogeneic cell therapies.

Using advanced technologies and tailored solutions from clinical to commercial supply, Catalent brings better biologic and advanced treatments to patients, faster.

About Catalent

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs.

Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply around 80 billion doses of nearly 8,000 products annually. Catalent’s expert workforce of approximately 19,000 includes more than 3,000 scientists and technicians.

Headquartered in Somerset, New Jersey, the company generated nearly $5 billion in revenue in its 2022 fiscal year. For more information, visit http://www.catalent.com.

More products. Better treatments. Reliably supplied™.

Share article on social media or email:

Recipients Of 2022 Congressional Bone Health Champion Award Announced


News Image

The Bone Health and Osteoporosis Foundation (BHOF) is pleased to announce the 2022 recipients of our national award to recognize Members of Congress who have demonstrated outstanding leadership, advocacy, and commitment to protect and improve the bone health of Americans. The awards are presented annually by BHOF to highlight the importance of bone health and the osteoporosis crisis in the U.S., and the work by national leaders to advance improvements in bone health policy.

The 2022 Congressional Bone Health Champion Award winners are:

Senator Shelley Moore Capito (R-WV): Senator Capito is one of the lead sponsors of the bipartisan legislation, S. 1943, the Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021. She is a leader in supporting many women’s health issues in Congress and has introduced legislation to support them.

Senator Patty Murray (D-WA): Senator Murray is the Chair of the Labor, Health and Human Services, Education and Related Agencies Appropriations panel. This year’s Senate appropriations report for the first time calls for a national education campaign to promote greater education and awareness about bone health and osteoporosis.

Representative Michael Burgess (R-TX): Representative Burgess was one of the original sponsors of H.R. 3517, Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021. Dr. Burgess has a longstanding history of support for improving bone health having previously been a member of the House Osteoporosis Caucus.

Representative Linda Sánchez (D-CA): Representative Sánchez is one of the lead sponsors of bipartisan legislation, H.R.3517, the Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021.

“Bone health is crucial to your overall health. Congress needs to prioritize bone health on our nation’s healthcare agenda, and pass legislation to improve bone health awareness, screening and care. We know it will have a dramatic impact on improving quality of life and reducing costly osteoporotic fractures,” said Claire Gill, CEO of the Bone Health and Osteoporosis Foundation

Osteoporosis is a growing yet often ignored health care problem that disproportionately impacts women. Ten million Americans have osteoporosis and 44 million are at high risk of the disease due to low bone density. According to a 2021 report, two million Medicare beneficiaries (about 70 percent women) suffered up to 2.1 million osteoporotic bone fractures in 2016. For women, the risk of any osteoporotic fracture is greater than their risk of a heart attack, stroke or breast cancer combined. The total annual cost for osteoporotic fractures among Medicare beneficiaries was $57 billion in 2018 and is expected to grow to over $95 billion in 2040 without reforms, as the population ages.

# # #

About the Bone Health and Osteoporosis Foundation

The Bone Health and Osteoporosis Foundation, formerly the National Osteoporosis Foundation, is the leading health organization dedicated to preventing osteoporosis and broken bones, promoting strong bones for life and reducing human suffering through programs of public and clinician awareness, education, advocacy and research. Established in 1984, BHOF is the nation’s largest health organization dedicated to osteoporosis and bone health.

Share article on social media or email:

Sagora Senior Living Named New Operator for Four Nebraska Communities


Sagora Senior Living is proud to announce that it has been named the operator of four communities in Nebraska

“Our growth allows us to better serve residents and drive positive change in their lives by providing them with an exceptional living experience,” Sagora Senior Living President Bryan McCaleb said.

Sagora Senior Living is now the operator of four senior living communities located in the state of Nebraska effective today, October 20, 2022. The addition of these communities expands Sagora Senior Living’s operations to 61 communities across 12 states.

“We are looking forward to the opportunity to expand our Resident First philosophy and further enrich the lives of seniors,” Sagora Senior Living President Bryan McCaleb said. “Our growth allows us to better serve residents and drive positive change in their lives by providing them with an exceptional living experience.”

Sagora Senior Living has begun to implement its core values and standards in these communities and will continue to do so over the next few months. Each community has been rebranded under the Bailey Pointe name, which serves to reflect the comfortable, home-like atmosphere of these communities while honoring the state’s railroad heritage and the role it played in shaping America.

The newly operated Sagora communities include:

  •     The Windcrest on Van Dorn in Lincoln, Nebraska, now rebranded as Bailey Point Assisted Living at Van Dorn
  •     The Waterford at Miracle Hills in Omaha, Nebraska, now rebranded as Bailey Point Assisted Living at Miracle Hills
  •     The Waterford at Roxbury Park in Omaha, Nebraska, now rebranded as Bailey Point Assisted Living at Roxbury Park
  •     The Waterford at Woodbridge in Plattsmouth, Nebraska, now rebranded as Bailey Point Assisted Living at Plattsmouth


ABOUT SAGORA SENIOR LIVING

Sagora Senior Living is among the nation’s Top-50 senior housing providers and is built upon a Resident First philosophy. The company operates 61 senior living communities with Cottages, Independent Living, Assisted Living and Memory Care living options. Sagora Senior Living’s communities span 12 states: Texas, California, Oklahoma, Illinois, New York, Ohio, West Virginia, Florida, North Dakota, Nebraska, Alabama and Mississippi. For additional information, please visit Sagora.com.

Share article on social media or email: